litlas
ログインアカウント作成

Giuseppe Tonini

1994–2025 年に発表

146
論文数
21,710
被引用数
79
h 指数
142
i10 指数

被引用数

Giuseppe Tonini の年別被引用数1978 年: 被引用 1 件1994 年: 被引用 5 件1995 年: 被引用 2 件1996 年: 被引用 9 件1997 年: 被引用 5 件1998 年: 被引用 10 件1999 年: 被引用 13 件2000 年: 被引用 8 件2001 年: 被引用 14 件2002 年: 被引用 18 件2003 年: 被引用 28 件2004 年: 被引用 32 件2005 年: 被引用 56 件2006 年: 被引用 56 件2007 年: 被引用 59 件2008 年: 被引用 79 件2009 年: 被引用 98 件2010 年: 被引用 147 件2011 年: 被引用 176 件2012 年: 被引用 158 件2013 年: 被引用 114 件2014 年: 被引用 158 件2015 年: 被引用 153 件2016 年: 被引用 148 件2017 年: 被引用 149 件2018 年: 被引用 140 件2019 年: 被引用 599 件2020 年: 被引用 707 件2021 年: 被引用 764 件2022 年: 被引用 629 件2023 年: 被引用 470 件2024 年: 被引用 884 件2025 年: 被引用 455 件2026 年: 被引用 14 件1979〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,714 件、この内訳の 18.3%イタリア: 引用元論文 1,146 件、この内訳の 12.2%中国: 引用元論文 1,112 件、この内訳の 11.9%イギリス: 引用元論文 493 件、この内訳の 5.2%ドイツ: 引用元論文 419 件、この内訳の 4.5%フランス: 引用元論文 381 件、この内訳の 4.1%スペイン: 引用元論文 357 件、この内訳の 3.8%日本: 引用元論文 356 件、この内訳の 3.8%オーストラリア: 引用元論文 240 件、この内訳の 2.5%カナダ: 引用元論文 232 件、この内訳の 2.5%オランダ: 引用元論文 222 件、この内訳の 2.4%韓国: 引用元論文 199 件、この内訳の 2.1%
0%18.3%その他 26.7%

機関

分野

  • Medicine70.8%
  • Biochemistry, Genetics and Molecular Biology20.8%
  • Immunology and Microbiology3.9%
  • Neuroscience0.7%
  • Engineering0.7%
  • Computer Science0.5%
  • その他2.6%

トピック

  • Colorectal Cancer Treatments and Studies7.1%
  • Cancer Immunotherapy and Biomarkers5.2%
  • Cancer Genomics and Diagnostics3.1%
  • Genetic factors in colorectal cancer2.5%
  • Hepatocellular Carcinoma Treatment and Prognosis2.5%
  • Lung Cancer Treatments and Mutations2.5%
  • その他77.1%

共著者

全論文

検索で開く
  1. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

    著者: Josep M. Llovet, Masatoshi Kudo, Philippe Merle, Tim Meyer, Shukui Qin, Masafumi Ikeda, Ruocai Xu, Julien Edeline, Baek‐Yeol Ryoo, Zhenggang Ren, Gianluca Masi, Mariusz Kwiatkowski, Ho Yeong Lim, Jee Hyun Kim, В. В. Бредер, Hiromitsu Kumada, Ann‐Lii Cheng, Peter R. Galle, Shuichi Kaneko, Anran Wang, Kalgi Mody, Corina E. Dutcus, Leonid Dubrovsky, Abby B. Siegel, Richard S. Finn, Simone I. Strasser, Alexander Thompson, Aflah Roohullah, William Sievert, Vladimir Andelkovic, Jennifer J. Knox, Janine M. Davies, Jamil Asselah, Mayur Brahmania, Habeeb Majeed, Luis J. Villanueva-Rivera, Patricio Yañez Weber, Marcelo Garrido, Gonzalo Pizarro, Nicolás Yáñez, Ruocai Xu, Shuangyan Ou, Zhenggang Ren, Hongming Pan, Zhiqiang Meng, Kangsheng Gu, Xi Chen, Tao Zhang, Chunyi Hao, Peiguo Cao, Yabing Guo, Shukui Qin, Juxiang Xiao, Weijia Fang, Xin Wang, Yuxian Bai, Xiaoming Chen, Dong Yan, Hong Zhao, Jieer Ying, Carlos Bonilla, Olga Urrego, Ángela R. Zambrano, Mauricio Lema, Juan Carlos Restrepo, Andrés F. Cardona, Sandra Franco Millan, Madiedo Oscar, Víctor Ramos, Philippe Merle, Samuel Lesourd, Julien Edeline, Jean–Pierre Bronowicki, Marc Bourlière, Stéphane Cattan, Mohamed Bouattour, Laurent Mineur, Hélène Regnault, Barbara Dauvois, Kornelius Schulze, Gunnar Folprecht, Andreas Geier, Oliver Waidmann, Fabian Finkelmeier, Marino Venerito, Marie‐Luise Berres, Thomas Berg, Christian M. Lange, Hartmut Schmidt, Dirk Waldschmidt, Michael Bitzer, Ray McDermott, Austin G. Duffy, Gianluca Masi, Vittorina Zagonel, Giuseppe Tonini, Fabio Piscaglia, Stefania Gori, Mimma Rizzo, Elisa Biscaldi ほか 109 名 - The Lancet Oncology 2023 被引用: 421

  2. Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

    著者: David Miles, Joseph Gligorov, Fabrice André, David Cameron, Andreas Schneeweiß, Carlos H. Barrios, Binghe Xu, Andrew Wardley, Diego Kaen, Livia Andrade, Semiglazov Vf, Mattea Reinisch, Shilpen Patel, Monika Patre, L. Morales, Sipahee Lal Patel, Manika Kaul, Teresa Barata, Joyce O’Shaughnessy, Q. Zhang, Binghe Xu, Zhimin Shao, Xiangyu Wang, Cuizhi Geng, Xingchen Yan, Zhongsheng Tong, Kunwei Shen, Yongmei Yin, Tao Sun, James Chih‐Hsin Yang, J Feng, Min Yan, Yan Wang, Qiang Liu, S. Zhang, Michelino De Laurentiis, Armando Santoro, Valentina Guarneri, Marco Colleoni, Clara Natoli, Laura Cortesi, Sabino De Placido, Lorenzo Gianni, Francesco Ferraù, Lorenzo Livi, Alberto Zambelli, Lucia Del Mastro, Giuseppe Tonini, Filippo Montemurro, Giulia Bianchi, R. Pedersini, Salvatore A. Del Prete, Giacomo Allegrini, Giuseppe Naso, Patrizia Vici, D. Loirat, Audrey Mailliez, Franck Priou, Olivier Trédan, F. Dalenc, Christophe Perrin, Joseph Gligorov, Morales-Pancorbo David, Nadine Dohollou, Luís Teixeira, Fabien Brocard, Antoine Arnaud, Suzette Delaloge, Jean‐Philippe Spano, Luigi Mansi, Livia Andrade, Fernanda Damian, José Luiz Pedrini, Sandra M. Aleixo, Roberto Hegg, R. Junior, Mattea Reinisch, Marcus Schmidt, C. Wenzel, E.‐M. Grischke, Andreas Schneeweiß, Marianne Just, Nadia Harbeck, Claudia Schumacher, Ubong Peters, Dorothea Fischer, Helmut Forstbauer, Rüdiger Liersch, Ellen Warner, Nathaniel Bouganim, C. T. Doyle, Julie Price Hiller, Ted Vandenberg, Michel Pavic, Andrew Robinson, Gloria Roldan Urgoiti, Nadia Califaretti, Ahmet Alacacıoğlu, M. Gumus, Bülent Yalçın ほか 68 名 - Annals of Oncology 2021 被引用: 729

  3. The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

    著者: Giovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti, Federica Morano, Roberto Moretto, Salvatore Corallo, Federica Marmorino, Sara Lonardi, Lorenza Rimassa, Andrea Sartore‐Bianchi, Beatrice Borelli, Marco Tampellini, Sara Bustreo, Matteo Claravezza, Alessandra Boccaccino, Roberto Murialdo, Alberto Zaniboni, Gianluca Tomasello, Fotios Loupakis, Vincenzo Adamo, Giuseppe Tonini, Enrico Cortesi, Filippo de Braud, Chiara Cremolini, Filippo Pietrantonio - British Journal of Cancer 2020 被引用: 354

  4. Gut Microbiota and Cancer: From Pathogenesis to Therapy

    著者: Silvia Vivarelli, Rossella Salemi, Saverio Candido, Luca Falzone, Maria Santagati, Stefania Stefani, Francesco Torino, Giuseppe Luigi Banna, Giuseppe Tonini, Massimo Libra - Cancers 2019 被引用: 578

  5. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    著者: Wendy De Roock, Bart Claes, David Bernasconi, Jef De Schutter, Bart Biesmans, George Fountzilas, Konstantine T. Kalogeras, Vassiliki Kotoula, Demetris Papamichael, Pierre Laurent‐Puig, Frédérique Penault–Llorca, Philippe Rougier, Bruno Vincenzi, Daniele Santini, Giuseppe Tonini, Federico Cappuzzo, Milo Frattini, Francesca Molinari, Piercarlo Saletti, Sara De Dosso, Miriam Martini, Alberto Bardelli, Salvatore Siena, Andrea Sartore‐Bianchi, Josep Tabernero, Teresa Macarulla, Frédéric FIORE, Alice Gangloff, Fortunato Ciardiello, Per Pfeiffer, Camilla Qvortrup, Tine Plato Hansen, Eric Van Cutsem, Hubert Piessevaux, Diether Lambrechts, Mauro Delorenzi, Sabine Tejpar - The Lancet Oncology 2010 被引用: 2,143

  6. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

    著者: Chiara Cremolini, Fotios Loupakis, Carlotta Antoniotti, Cristiana Lupi, Elisa Sensi, Sara Lonardi, Silvia Mezi, Gianluca Tomasello, Monica Ronzoni, Alberto Zaniboni, Giuseppe Tonini, Chiara Carlomagno, Giacomo Allegrini, Silvana Chiara, Mauro D’Amico, Cristina Granetto, Marina Elena Cazzaniga, Luca Boni, Gabriella Fontanini, Alfredo Falcone - The Lancet Oncology 2015 被引用: 1,093

  7. Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

    著者: Fotios Loupakis, Chiara Cremolini, Gianluca Masi, Sara Lonardi, Vittorina Zagonel, Lisa Salvatore, Enrico Cortesi, Gianluca Tomasello, Monica Ronzoni, Rosella Spadi, Alberto Zaniboni, Giuseppe Tonini, Angela Buonadonna, D. Amoroso, Silvana Chiara, Chiara Carlomagno, C. Boni, Giacomo Allegrini, Luca Boni, Alfredo Falcone - New England Journal of Medicine 2014 被引用: 1,078

  8. Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study

    著者: Maurizio Muscaritoli, the PreMiO Study Group, Simone Lucia, Alessio Farcomeni, Vito Lorusso, V. Saracino, Carlo Barone, Francesca Plastino, Stefania Gori, Roberto Magarotto, Giacomo Cartenì, Bruno Chiurazzi, Ida Pavese, Luca Marchetti, Vittorina Zagonel, Eleonora Bergo, Giuseppe Tonini, Marco Imperatori, Carmelo Iacono, Luigi Maiorana, Carmine Pinto, Daniela Rubino, Luigi Cavanna, Roberto Di Cicilia, Teresa Gamucci, Silvia Quadrini, Salvatore Palazzo, Stefano Minardi, Marco Merlano, Giuseppe Colucci, Paolo Marchetti - Oncotarget 2017 被引用: 424

  9. Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

    著者: Luis Paz‐Ares, Óscar Juan, Giannis Mountzios, Enriqueta Felip, Niels Reinmuth, Filippo de Marinis, Nicolas Girard, Vipul M. Patel, Takayuki Takahama, Scott Owen, Douglas Reznick, Firas Badin, İrfan Çiçin, Sabeen Mekan, Riddhi Patel, Éric Zhang, Divyadeep Karumanchi, Marina Chiara Garassino, Elizabeth Ahern, Venessa Chin, Stephen Della‐Fiorentina, Kevin Jasas, Christos S. Karapetis, Jeremy Long, Louise Nott, Kenneth J. O’Byrne, Craig Underhill, Richard Greil, Maximilian J. Hochmair, Andreas Pircher, Wim Demey, Paul Germonpré, Elke Govaerts, Thierry Pieters, Reinier Wener, Alan A. Azambuja, Giuliano Santos Borges, Gilberto de Castro, Suellen Castro, Felipe Melo Cruz, Fábio Franke, Eduardo Silva, Parneet Cheema, Robert H. El-Maraghi, Swati Kulkarni, Rami Nassabein, Scott Owen, Clarisse Audigier-Valette, Jaafar Bennouna, C. Chouaïd, Alexis B. Cortot, S. Couraud, D. Debieuvre, Fabrice Denis, Patrick Dumont, Radj Gervais, Nicolas Girard, Etienne Giroux‐Leprieur, Florian Guisier, Sandrine Hiret, Henri Janicot, Corinne Lamour, J. Madelaine, M. Marcq, E. Pluquet, Jean Louis Pujol, Magali Ravoire, Marielle Sabatini, A. Vergnenègre, Sabine Bohnet, Martin Faehling, Melanie Janning, Eckart Laack, Niels Reinmuth, Achim Rittmeyer, Claas Wesseler, Sofia Baka, George Fountzilas, Panagiotis Katsaounis, Αthanasios Kotsakis, Ioannis Mountzios, Konstantinos Syrigos, Julia Dudnik, Fink Carmel, Ofer Merimsky, Hovav Nechushtan, Julia Sobolev, Franceso Agustoni, Anna Bettini, Matteo Brighenti, Giulio Cerea, Filippo de Marinis, Salvatore Grisanti, Francesco Grossi, Andrea Luciani, Evaristo Maiello, Héctor Soto Parrà, Pierfrancesco Tassone, Giuseppe Tonini, Yoko Agemi ほか 101 名 - Journal of Clinical Oncology 2024 被引用: 115

  10. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples

    著者: Marco Russano, Andrea Napolitano, Giulia Ribelli, Michele Iuliani, Sonia Simonetti, Fabrizio Citarella, Francesco Pantano, Emanuela Dell’Aquila, Cecilia Anesi, Nicola Silvestris, Antonella Argentiero, Antonio Giovanni Solimando, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini - Journal of Experimental & Clinical Cancer Research 2020 被引用: 254

  11. Assessment of a HER2 scoring system for colorectal cancer: results from a validation study

    著者: Emanuele Valtorta, Cosimo Martino, Andrea Sartore‐Bianchi, Frédérique Penaullt-Llorca, Giuseppe Viale, Mauro Risio, Massimo Rugge, Walter Grigioni, Katia Bencardino, Sara Lonardi, Vittorina Zagonel, Francesco Leone, Johannes Noé, Fortunato Ciardiello, Carmine Pinto, Roberto Labianca, Stefania Mosconi, Claudio Graiff, Giuseppe Aprile, Barbara Frau, Carlo Garufi, Fotios Loupakis, Patrizia Racca, Giuseppe Tonini, Calogero Lauricella, Silvio Veronese, Mauro Truini, Salvatore Siena, Silvia Marsoni, Marcello Gambacorta - Modern Pathology 2015 被引用: 317

  12. Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

    著者: Benjamin Besse, Enriqueta Felip, Rosario García Campelo, Manuel Cobo, Céline Mascaux, Anne Madroszyk, Federico Cappuzzo, Werner Hilgers, Gianpiero Romano, Fabrice Denis, Santiago Viteri, D. Debieuvre, Domenico Galetta, Editta Baldini, M. Razaq, G. Robinet, Michele Maio, Angelo Delmonte, Benoît Roch, Patrick Masson, Wolfgang Schuette, Alona Zer, Jordi Remón, D Costantini, B. Vasseur, Rafał Dziadziuszko, Giuseppe Giaccone, Milada Zemanová, Benjamin Besse, Clément Bonnet, Jacques Cadranel, C. Chouaïd, Alexis B. Cortot, D. Debieuvre, B. Delclaux, Fabrice Denis, Boris Duchemann, Claude El Kouri, François‐Régis Ferrand, M. Ginoux, Werner Hilgers, Anne Madroszyk, Patrick Masson, Julien Mazières, O. Molinier, Denis Moro‐Sibilot, Éric Pichon, Céline Mascaux, G. Robinet, Benoît Roch, Gérard Zalcman, Gerlinde Schmidtke-Schrezenmeier, Wolfgang Schuette, László Urbán, Maya Gottfried, Hovav Nechushtan, Nir Peled, M. Wollner, Alona Zer, Editta Baldini, Laura Bonanno, Andrea Bonetti, Federico Cappuzzo, Angelo Delmonte, Domenico Galetta, Michele Maio, V. Minotti, Antonio Rea, Gianpiero Romano, Davide Tassinari, Giuseppe Tonini, Rafał Dziadziuszko, Bogusława Karaszewska, Aleksandra Szczęsna, Manuel Cobo, J. De Castro, Enriqueta Felip, M.R. García Campelo, Ainhoa Hernández, Teresa Morán, Mariano Provencio, Santiago Viteri, Abhijit Dasgupta, Nashat Gabrail, Giuseppe Giaccone, A. Harshad, Stephen V. Liu, D. Oubre, Rajiv Panikkar, M. Razaq, Rachel E. Sanborn - Annals of Oncology 2023 被引用: 70

  13. Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis

    著者: Francesca Romana Bertani, Pamela Mozetic, Marco Fioramonti, Michele Iuliani, Giulia Ribelli, Francesco Pantano, Daniele Santini, Giuseppe Tonini, Marcella Trombetta, Luca Businaro, S. Selci, Alberto Rainer - Scientific Reports 2017 被引用: 234

  14. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)

    著者: E Cacciari, Silvano Milani, Antonio Balsamo, Elena Spada, Gianni Bona, Luciano Cavallo, F. Cerutti, L Gargantini, Nella Augusta Greggio, Giuseppe Tonini, Alessandro Cicognani - Journal of Endocrinological Investigation 2006 被引用: 809

  15. Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer

    著者: Alessio Cortellini, Antonio D’Alessio, Siobhan Cleary, Sebastiano Buti, Melissa Bersanelli, Paola Bordi, Giuseppe Tonini, Bruno Vincenzi, Marco Tucci, Alessandro Russo, Francesco Pantano, Marco Russano, Luigia Stefania Stucci, Maria Chiara Sergi, Martina Falconi, Maria Antonietta Zarzana, Daniele Santini, Francesco Spagnolo, Enrica T. Tanda, Francesca Rastelli, Francesca Chiara Giorgi, Federica Pergolesi, Raffaele Giusti, Marco Filetti, Francesca Lo Bianco, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Marco Siringo, Marco Ferrari, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Michele Ghidini, Olga Nigro, Francesco Grossi, Michele De Tursi, Pietro Di Marino, Paola Queirolo, Sergio Bracarda, Serena Macrini, Alessandro Inno, Federica Zoratto, Enzo Veltri, Chiara Spoto, Maria Grazia Vitale, Katia Cannita, Alessandra Gennari, Daniel L. Morganstein, Domenico Mallardo, Lorenzo Nibid, Giovanna Sabarese, Leonardo Brunetti, Giuseppe Perrone, Paolo A. Ascierto, Corrado Ficorella, David J. Pinato - Clinical Cancer Research 2023 被引用: 74

  16. Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study

    著者: Alessandro Russo, Marco Russano, Tindara Franchina, Maria Rita Migliorino, Giuseppe Aprile, Giovanni Mansueto, Alfredo Berruti, Alfredo Falcone, Michele Aieta, Alain Gelibter, Antonio Russo, Sandro Barni, Michele Maio, Olga Martelli, Francesco Pantano, Daniela Iacono, Lorenzo Calvetti, Silvia Quadrini, Elisa Roca, Enrico Vasile, Marco Imperatori, Mario Occhipinti, Antonio Galvano, Fausto Petrelli, Luana Calabrò, G. Pasquini, Salvatore Intagliata, Giuseppina Rosaria Rita Ricciardi, Giuseppe Tonini, Daniele Santini, Vincenzo Adamo - Advances in Therapy 2020 被引用: 168

  17. Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial

    著者: Maria Carmela Piccirillo, Laura Bonanno, Marina Chiara Garassino, Giovanna Esposito, Claudio Dazzi, Luigi Cavanna, Marco Angelo Burgio, Francesco Rosetti, Simona Rizzato, Floriana Morgillo, Saverio Cinieri, Antonello Veccia, Maximilan Papi, Giuseppe Tonini, Vittorio Gebbia, Serena Ricciardi, Daniele Pozzessere, Alessandra Ferro, Claudia Proto, Raffaele Costanzo, M. D’Arcangelo, Manuela Proietto, Piera Gargiulo, Raimondo Di Liello, Laura Arenare, Filippo de Marinis, Lucio Crinò, Fortunato Ciardiello, Nicola Normanno, Ciro Gallo, Francesco Perrone, Cesare Gridelli, Alessandro Morabito - Journal of Thoracic Oncology 2022 被引用: 68

  18. Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

    著者: Daniele Santini, Bruno Vincenzi, Raffaele Addeo, Carlo Garufi, Gianluca Masi, Mario Scartozzi, Andrea Mancuso, Anna Maria Frezza, Olga Venditti, Marco Imperatori, Gaia Schiavon, Giuseppe Bronte, Giuseppe Cicero, Federica Recine, Evaristo Maiello, Stefano Cascinu, Antonio Russo, Alfredo Falcone, Giuseppe Tonini - Annals of Oncology 2012 被引用: 213

  19. Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions

    著者: Francesco Pantano, Martine Croset, Keltouma Driouch, Natalia Bednarz‐Knoll, Michele Iuliani, Giulia Ribelli, Edith Bonnelye, Harriet Wikman, Sandra Geraci, Florian Bonin, Sonia Simonetti, Bruno Vincenzi, Saw See Hong, Sofia Sousa, Klaus Pantel, Giuseppe Tonini, Daniele Santini, Philippe Clézardin - Oncogene 2021 被引用: 100

  20. Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study

    著者: Giulia Bon, Laura Pizzuti, Valentina Laquintana, Rossella Loria, Manuela Porru, Caterina Marchiò, Eriseld Krasniqi, Maddalena Barba, Marcello Maugeri‐Saccà, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali, Nicla La Verde, Alessandra Cassano, Emilio Bria, Luca Moscetti, Andrea Michelotti, Vincenzo Adamo, Claudio Zamagni, Giuseppe Tonini, Giacomo Barchiesi, Marco Mazzotta, Daniele Marinelli, Federica Tomao, Paolo Marchetti, Maria Rosaria Valerio, Rosanna Mirabelli, Antonio Russo, Agnese Fabbri, Nicola D’Ostilio, Enzo Veltri, Domenico Corsi, Ornella Garrone, Ida Paris, Giuseppina Sarobba, Francesco Giotta, Carlo Garufi, Marina Elena Cazzaniga, Pietro Del Medico, Mario Roselli, Giuseppe Sanguineti, Isabella Sperduti, Anna Sapino, Ruggero De Maria, Carlo Leonetti, Angelo Di Leo, Gennaro Ciliberto, Rita Falcioni, Patrizia Vici - Journal of Experimental & Clinical Cancer Research 2020 被引用: 75

  21. KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer

    著者: Fotios Loupakis, Annamaria Ruzzo, Chiara Cremolini, Bruno Vincenzi, Lisa Salvatore, Daniele Santini, Gianluca Masi, I. Stasi, Emanuele Canestrari, Eliana Rulli, Irene Floriani, Katia Bencardino, Nadia Galluccio, Vincenzo Catalano, Giuseppe Tonini, Mauro Magnani, Gabriella Fontanini, Fulvio Basolo, Alfredo Falcone, Francesco Graziano - British Journal of Cancer 2009 被引用: 561

  22. Short-Term Benefits of Smoking Cessation Improve Respiratory Function and Metabolism in Smokers

    著者: Aldo Pezzuto, Alberto Rícci, Michela D’Ascanio, Alba Moretta, Giuseppe Tonini, Noemi Calabrò, Valeria Minoia, Alessia Pacini, Giuliana De Paolis, Eleonora Chichi, Elisabetta Carico, Antonella Tammaro - International Journal of COPD 2023 被引用: 50

  23. Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation

    著者: Sara Lonardi, Cosimo Rasola, Riccardo Lobefaro, Daniele Rossini, Vincenzo Formica, Mario Scartozzi, Giovanni Luca Frassineti, Giorgia Boscolo, Saverio Cinieri, Samantha Di Donato, Nicoletta Pella, Francesca Bergamo, Alessandra Raimondi, Ermenegildo Arnoldi, Lorenzo Antonuzzo, Cristina Granetto, Fable Zustovich, Monica Ronzoni, Silvana Leo, Federica Morano, Fotios Loupakis, Federica Buggin, Vittorina Zagonel, Matteo Fassan, Chiara Cremolini, Luca Boni, Filippo Pietrantonio, Ermenegildo Arnoldi, Lorenzo Antonuzzo, Giuseppe Aprile, Antonio Ardizzoia, C. Aschele, Editta Baldini, Alberto Ballestrero, Alessandro Bertolini, Roberto Bordonaro, Giorgia Boscolo, Angela Buonadonna, Saverio Cinieri, Matteo Clavarezza, Domenico Corsi, Enrico Cortesi, Filippo de Braud, Samantha Di Donato, Alfredo Falcone, Adolfo Favaretto, Vincenzo Formica, Luca Frassineti, Antonio Frassoldati, M. Frisinghelli, Teresa Gamucci, Luca Gianni, Filippo Giovanardi, Stefania Gori, Roberta Grande, Cristina Granetto, Silvana Leo, Francesco Leone, Sara Lonardi, Andrea Luciani, Carlo Milandri, Nicoletta Pella, Andrea Sartore‐Bianchi, Mario Scartozzi, Nicola Silvestris, Emiliano Tamburini, Gianluca Tomasello, Giuseppe Tonini, Gianpaolo Tortora, Claudio Vergani, Albrto Zaniboni, Fable Zustovich - Journal of Clinical Oncology 2023 被引用: 40

  24. CAR-T cell therapy: a potential new strategy against prostate cancer

    著者: Giuseppe Schepisi, Maria Concetta Cursano, Chiara Casadei, Cecilia Menna, Amelia Altavilla, Cristian Lolli, Claudio Cerchione, Giovanni Paganelli, Daniele Santini, Giuseppe Tonini, Giovanni Martinelli, Ugo De Giorgi - Journal for ImmunoTherapy of Cancer 2019 被引用: 93